Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth (Review)

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2006, Pages

  Roberts, D ^a   Dalziel, S ^b  

^a LIVERPOOL WOMEN'S NHS FOUNDATION TRUST   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CORTICOSTEROID DERIVATIVE; DEXAMETHASONE; HYDROCORTISONE; PLACEBO;

ADULTHOOD; ASSISTED VENTILATION; AUTHOR; BIRTH; BRAIN HEMORRHAGE; CEREBROVENTRICULAR HEMORRHAGE; CHILDBIRTH; CHORIOAMNIONITIS; CHRONIC LUNG DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DATA EXTRACTION; DRUG EFFECT; FETUS LUNG MATURATION; FETUS MORTALITY; HOSPITAL ADMISSION; HUMAN; INFORMATION; INTENSIVE CARE UNIT; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; MEMBRANE RUPTURE; MOTHER; MULTIPLE PREGNANCY; NECROTIZING ENTEROCOLITIS; NEWBORN DEATH; NEWBORN MORBIDITY; NEWBORN MORTALITY; NONHUMAN; PREGNANCY; PREMATURE LABOR; PRENATAL PERIOD; PUERPERAL INFECTION; REGISTER; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK FACTOR;

EID: 37649028033     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004454.pub2     Document Type: Review

References (118)

1. Amorim MM, Santos LC, Faundes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. American Journal of Obstetrics and Gynecology 1999;180(5):1283-8.
2. Block MF, Kling OR, Crosby WM. Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant. Obstetrics & Gynecology 1977;50:186-90.
3. Botet F, Cararach V, Sentis J. Premature rupture of membranes in early pregnancy. Neonatal prognosis. Journal of Perinatal Medicine 1994;22:45-52.
4. Cararach V, Botet F, Sentis J, Carmona F. A multicenter, prospective randomized study in premature rupture of membranes (PROM). Maternal and perinatal complications. Proceedings of the 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991; Singapore. 1991:267.
5. * Cararach V, Sentis J, Botet F, De Los Rios L. Amulticenter, prospective randomized study in premature rupture ofmembranes (PROM). Respiratory and infectious complications in the newborn. Proceedings of the 12th European Congress of Perinatal Medicine; 1990; Lyon, France. 1990:216.
6. Carlan SJ, Parsons M, O'Brien WF, Krammer J. Pharmacologic pulmonary maturation in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology 1991;164:371.
7. Bauer CR, Morrison JC, Poole WK, Korones SB, Boehm JJ, Rigatto H, et al. A decreased incidence of necrotizing enterocolitis after prenatal glucocorticoid therapy. Pediatrics 1984;73:682-8.
8. Burkett G, Bauer CR, Morrison JC, Curet LB. Effect of prenatal dexamethasone administration on the prevention of respiratory distress syndrome in twin pregnancies. Journal of Perinatology 1986;6:304-8.
9. Collaborative Group on Antenatal Steroid Therapy. Amniotic fluid phospholipids after maternal administration of dexamethasone. American Journal of Obstetrics and Gynecology 1983;145:484-90.
10. Collaborative Group on Antenatal Steroid Therapy. Effect of antenatal dexamethasone administration in the infant: long term followup. Journal of Pediatrics 1984;105:259-67.
11. * Collaborative Group on Antenatal Steroid Therapy. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology 1981;141:276-87.
12. Curet LB, Rao AV RD, Zachman RD, Morrison J, Burkett G, Poole K, et al. Maternal smoking and respiratory distress syndrome. American Journal of Obstetrics and Gynecology 1983;147:446-50.
13. Haning RV, Curet LB, Poole K, Boehnlein LM, Kuzma DL, Meier SM. Effects of fetal sex and dexamethasone on preterm maternal serum concentrations of human chorionic gonadotropin, progesterone, estrone, estradiol, and estriol. American Journal of Obstetrics and Gynecology 1989;161:1549-53.
14. Wiebicke W, Poynter A, Chernick V. Normal lung growth following antenatal dexamethasone treatment for respiratory distress syndrome. Pediatric Pulmonology 1988;5:27-30.
15. Zachman RD. The NIH multicenter study and miscellaneous clinical trials of antenatal corticosteroid administration. In: Farrell PM editor(s). Lung development: biological and clinical perpectives. Vol. II, London & New York: Academic Press, 1982:275-96.
16. Zachman RD, Bauer CR, Boehm J, Korones SB, Rigatto H, Rao AV. Effect of antenatal dexamethasone on neonatal leukocyte count. Journal of Perinatology 1988;8:111-3.
17. Pattinson RC. A meta-analysis of the use of corticosteroids in pregnancies complicated by preterm premature rupture of membranes. South African Medical Journal 1999;89(8):870-3.
18. Pattinson RC, Funk M, Makin JD, Ficki H. The effect of dexamethasone on the immune system of women with preterm premature rupture of membranes: a randomised controlled trial. 15th Conference on Priorities in Perinatal Care in Southern Africa; 1996 March 5-8; Goudini Spa, South Africa. 1996.
19. * Pattinson RC, Makin JD, Funk M, Delport SD, Macdonald AP, Norman K. The use of dexamethasone in women with preterm premature rupture of membranes: a multicentre double blind, placebo controlled randomised trial. South African Medical Journal 1999;89 (8):865-70.
20. Pattinson RC, Makin JD, Funk M, Delport SD, Macdonald AP, Norman K, et al. The use of dexamethasone in women with preterm premature rupture of membranes: a multicentre placebo controlled randomised controlled trial. 16th Conference on Priorities in Perinatal Care; 1997; South Africa. 1997:32-4.
21. Doran TA, Swyer P, MacMurray B, Mahon W, Enhorning G, Bernstein A, et al. Results of a double blind controlled study on the use of betamethasone in the prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology 1980;136:313-20.
22. Fekih M, Chaieb A, Sboui H, Denguezli W, Hidar S, Khairi H. Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study [Apport de la corticotherapie antenatale dans la prevention de lamaladie des membranes hyalines chez le premature. Etude prospective randomisee]. Tunisie Medicale 2002;80(5):260-5.
23. Donnai P. UK multicentre trial of betamethasone for the prevention of respiratory distress syndrome. Proceedings of the 6th European Congress of Perinatal Medicine; 1989; Vienna, Austria. 1978:81.
24. * Gamsu HR, Mullinger BM, Donnai P, Dash CH. Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: report of a UK multicentre trial. British Journal of Obstetrics and Gynaecology 1989;96:401-10.
25. Garite TJ, Rumney PJ, Briggs GG. A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24-28 weeks gestation. Surgery, Gynecology and Obstetrics 1993;176:37.
26. * Garite TJ, Rumney PJ, Briggs GG, Harding JA, Nageotte MP, Towers CV, et al. A randomized placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24-28 weeks gestation. American Journal of Obstetrics and Gynecology 1992;166:646-51.
27. Eronen M, Kari A, Pesonen E, Hallman M. The effect of antenatal dexamethasone administration on the fetal and neonatal ductus arteriosus: a randomised double-blind study. American Journal of Diseases of Children 1993;147:187-92.
28. Kari MA, Akino T, Hallman M. Prenatal dexamethasone (DEX) treatment before preterm delivery and rescue therapy of exogenous surfactant- surfactant components and surface activity in airway specimens (AS). Proceedings of the 14th European Congress of Perinatal Medicine; 1994; Helsinki, Finland. 1994:486.
29. * Kari MA, Hallman M, Eronen M, Teramo K, Virtanen M, Koivisto M, et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomised placebo-controlled multicenter study. Pediatrics 1994;93:730-6.
30. Salokorpi T, Sajaniemi N, Hallback H, Kari A, Rita H, von Wendt L. Randomized study of the effect of antenatal dexamethasone on growth and development of premature children at the corrected age of 2 years. Acta Paediatrica 1997;86:294-8.
31. Lewis D, Brody K, Edwards M, Brouillette RM, Burlison S, London SN. Preterm premature rupturedmembranes: a randomized trial of steroids after treatment with antibiotics. Obstetrics & Gynecology 1996;88(5):801-5.
32. Dalziel SR, Liang A, Parag V, Rodgers A, Harding JE. Blood pressure at 6 years of age after prenatal exposure to betamethasone: follow-up results of a randomized, controlled trial. Pediatrics 2004;114:e373-e377.
33. Dalziel SR, Lim VK, Lambert A, McCarthy D, Parag V, Rodgers A, et al. Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ 2005;331:665-8.
34. Dalziel SR, Parag V, Harding JE. Blood pressure at 6 years of age following exposure to antenatal bethamethasone. 7th Annual Congress of the Perinatal Society of Australia and New Zealand; 2003 March 9-12; Tasmania, Australia. 2003:P13.
35. Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A, et al. Cardiovascular risk factors after exposure to antenatal betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 2005;365:1856- 62.
36. Harding JE, Pang J, Knight DB, Liggins GC. Do antenatal corticosteroids help in the setting of preterm rupture of membranes?. Amer-ican Journal of Obstetrics and Gynecology 2001;184:131-9.
37. Howie RN. Pharmacological acceleration of lung maturation. In: Villee CA, Villee DB, Zuckerman J editor(s). Respiratory distress syn-drome. London & New York: Academic Press, 1986:385-96.
38. Howie RN, Liggins GC. Clinical trial of antepartum betamethasone therapy for prevention of respiratory distress in pre-term infants. In: Anderson ABM, Beard RW, Brudenell JM, Dunn PM editor(s). Pre-term labour. London: RCOG, 1977:281-9.
39. Howie RN, Liggins GC. Prevention of respiratory distress syndrome in premature infants by antepartum glucocorticoid treatment. In: Villee CA, Villee DB, Zuckerman J editor(s). Respiratory distress syndrome. London & New York: Academic Press, 1973:369-80.
40. Howie RN, Liggins GC. The New Zealand study of antepartum glucocorticoid treatment. In: Farrell PM editor(s). Lung development: biological and clinical perspectives, II. Academic Press: London&New York, 1982:255-65.
41. Liggins GC. Prenatal glucocorticoid treatment: prevention of respiratory distress syndrome. Lung maturation and the prevention of hyaline membrane disease, report of 70th Ross Conference on Paediatric Research. Ross Labs, 1976:97-103.
42. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-25.
43. Liggins GC, Howie RN. Prevention of respiratory distress syndrome by antepartum corticosteroid therapy. Proceedings of Sir Joseph Barcroft Centenary Symposium, Fetal and Neonatal Physiology. Cambridge University Press, 1973:613-7.
44. Liggins GC, Howie RN. Prevention of respiratory distress syndrome by maternal steroid therapy. In: Gluck L editor(s). Modern perinatal medicine. Chicago: Yearbook Publishers, 1974:415-24.
45. MacArthur B, Howie RN, DeZoete A, Elkins J. Cognitive and psychosocial development of 4-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics 1981;68:638-43.
46. MacArthur B, Howie RN, DeZoete A, Elkins J. School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics 1982;70:99-105.
47. MacArthur B, Howie RN, DeZoete A, Elkins J, Liang AYL. Long term follow up of children exposed to betamethasone in utero. In: Tejani N editor(s). Obstetrical events and developmental sequelae. CRC Press, 1989:81-9.
48. Morales WJ, Angel JL, O'Brien WF, Knuppel RA. Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study. Obstetrics & Gynecology 1989;73:721-6.
49. Nelson LH, Meis PJ, Hatjis CG, Ernest JM, Dillard R, Schey HM. Premature rupture of membranes: a prospective randomized evaluation of steroids, latent phase and expectant management. Obstetrics & Gynecology 1985;66:55-8.
50. Parsons MT, Sobel D, Cummiskey K, Constantine L, Roitman J. Steroid, antibiotic and tocolytic vs no steroid, antibiotic and tocolytic management in patients with preterm PROM at 25-32 weeks. Proceedings of the 8th Annual Meeting of the Society of Perinatal Obstetricians; 1988; Las Vegas, Nevada. 1988:44.
51. Sobel D, Parsons M, Roitman J, McAlpine L, Cumminsky K. Antenatal antibiotics in PROM prevents congenital bacterial infection. Pediatric Research 1988;23:476A.
52. Qublan H, Malkawi H, Hiasat M, Hindawi IM, Al-Taani MI, Abu-Khait SA, et al. The effect of antenatal corticosteroid therapy on pregnancies complicated by premature rupture of membranes. Clinical & Experimental Obstetrics & Gynecology 2001;28(3):183-6.
53. Dessens AB, Haas HS, Koppe JG. Twenty year follow up of antenatal corticosteroid treatment. Pediatrics 2000;105(6):1325.
54. Dessens AB, Smolders-de Haas H, Koppe JG. Twenty year follow up in antenatally corticosteroid-treated subjects. Prenatal and Neonatal Medicine 1998;3 Suppl 1:32.
55. Schmand B, Neuvel J, Smolder-de Haas H, Hoeks J, Treffers PE, Koppe JG. Psychological development of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome. Pediatrics 1990;86:58-64.
56. Schutte MF, Koppe JG, Treffers PE, Breur W. The influence of 'treatment' in premature delivery on incidence of RDS. Proceedings of the 6th European Congress of Perinatal Medicine; 1978 August 29-September 1; Vienna, Austria. 1978.
57. * Schutte MF, Treffers PE, Koppe JG, Breur W. The influence of betamethasone and orciprenaline on the incidence of respiratory distress syndrome in the newborn after preterm labour. British Journal of Obstetrics and Gynaecology 1980;87:127-31.
58. Schutte MF, Treffers PE, Koppe JG, Breur W, Filedt Kok JC. The clinical use of corticosteroids for the acceleration of fetal lung maturity [Klinische toepassing van corticosteroiden ter bevordering van de foetale long-rijpheid]. Nederlands Tijdschrift voor Geneeskunde 1979;123:420-7.
59. Smolders-de Haas H, Neuvel J, Schmand B, Treffers PE, Koppe JG, Hoeks J. Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: a 10- to 12- year follow up. Pediatrics 1990;86(1):65-70.
60. Silver RK, Vyskocil CR, Solomon SL, Farrell EE, MacGregor SN, Neerhof MG. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered prior to 30 weeks of gestation. American Journal of Obstetrics and Gynecology 1995;172:254.
61. * Silver RK, Vyskocil CR, Solomon SL, Ragin A, Neerhof MG, Farrell EE. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered prior to 30 weeks of gestation. Obstetrics & Gynecology 1996;87:683-91.
62. Taeusch HW Jr, Frigoletto F, Kitzmiller J, Avery ME, Hehre A, Fromm B, et al. Risk of respiratory distress syndrome after prenatal dexamethasone treatment. Pediatrics 1979;63:64-72.
63. Teramo K, Hallman M, Raivio KO. Maternal glucocorticoid in unplanned premature labor. Pediatric Research 1980;14:326-9.
64. Abuhamad A, Green G, Heyl P, de Veciana M. The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial. American Journal of Obstetrics and Gynecology 1999;180(1 Pt 2):S96.
65. Butterfill AM, Harvey DR. Follow-up study of babies exposed to betamethasone before birth. Archives of Disease in Childhood 1979;54:725.
66. Dola C, Nageotte M, Rumney P, Towers C, Asrat T, Freeman R, et al. The effect of antenatal treatment with betamethasone and thyrotropin releasing hormone in patients with preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology 1997;176(1 Pt 2):S49.
67. Egerman RS, Mercer B, Doss JL, Sibai BM. A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. Acta Obstetricia et Gynecologica Scandinavica 1998;178(1 Pt 2):S19.
68. * Egerman RS, Mercer BM, Doss JL, Sibai BM. A randomized, controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology 1998;179(5):1120-3.
69. Egerman RS, Pierce WF 4th, Andersen RN, Umstot ES, Carr TL, Sibai BM. A comparison of the bioavailability of oral and intramuscular dexamethasone in women in late pregnancy. Obstetrics & Gynecology 1997;89(2): 276-80.
70. Egerman RS, Walker RA, Doss JL, Mercer B, Sibai BM, Andersen RN. A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology 1998;178(1 Pt 2):S182.
71. Egerman RS, Walker RA, Mercer BM, Doss JL, Sibai BM, Andersen RA. Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology 1998;179(5):1234-6.
72. Garite TJ, Freeman RK, Linzey EM, Braly PS, Dorchester WL. Prospective randomized study of corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology 1981;141:508-15.
73. Halac E, Halac J, Begue EF, Casanas JM, Idiveri DR, Petit JF, et al. Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial. Journal of Pediatrics 1990;117:132-8.
74. Iams JD, Talbert ML, Barrows H, Sachs L. Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology 1985;151:32-8.
75. Kuhn RJP, Speirs AL, Pepperell RJ, Eggers TR, Doyle LW, Hutchinson A. Betamethasone, albuterol and threatened premature delivery. Obstetrics & Gynecology 1982;60:403-8.
76. Magee LA, Dawes GS, Moulden M, Redman CW. A randomised controlled comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology 1997;104(11):1233-8.
77. Minoui S, Ville Y, Senat M, Multon O, Fernandez H, Frydman R. Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labour: a randomized study. British Journal of Obstetrics and Gynaecology 1998;105:749-55.
78. Minoui S, Ville Y, Senat MV, Multon O, Fernandez H, Frydman R. Effect of dexamethasone and betamethasone on fetal heart rate variability in pretermlabor a randomized study. Prenatal and Neonatal Medicine 1996;1 Suppl 1:156.
79. Morales WJ, Diebel D, Lazar AJ, Zadrozny D. The effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome in preterm gestations with prenature rupture of membranes. American Journal of Obstetrics and Gynecology 1986;154:591-5.
80. Morrison JC, Schneider JM, Whybrew WD, Bucovaz ET. Effect of corticosteroids and fetomaternal disorders on the L:S ratio. Surgery, Gynecology and Obstetrics 1981;153:464.
81. Morrison JC, Whybrew WD, Bucovaz ET, Scheiner JM. Injection of corticosteroids into mother to prevent neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology 1978;131:358-66.
82. Mulder EJ, Derks JB, Visser GH. Antenatal corticosteroid therapy and fetal behaviour: a randomised evaluation of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology 1997;104(11):1239- 47.
83. Papageorgiou AN, Desgranges MF, Masson M, Colle E, Shatz R, Gelfand MM. The antenatal use of betamethasone in the prevention of respiratory distress syndrome: a controlled blind study. Pediatrics 1979;63:73-9.
84. Rotmensch S, Liberati M, Vishne T, Celentano C, Ben-Rafael Z, Bellati U. The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology 1998;178(1 Pt 2):S185.
85. Rotmensch S, Liberati M, Vishne TH, Celentano C, Ben-Rafael Z, Bellati U. The effect of betamethasone and dexamethasone on the fetal heart rate patterns and biophysical activities. A prospective randomized trial. Acta Obstetricia et Gynecologica Scandinavica 1999;78(6):493-500.
86. Schmidt PL, Sims ME, Strassner HT, Paul RH, Mueller E, McCart D. Effect of antepartum glucocorticoid administration upon neonatal respiratory distress syndrome and perinatal infection. American Journal of Obstetrics and Gynecology 1984;148:178-86.
87. Simpson G, Harbert G. Use of beta-methasone in management of preterm gestation with premature rupture of membranes. Obstetrics & Gynecology 1985;66:168-75.
88. Whitt GG, Buster JE, Killam AP, Scragg WH. A comparison of two glucocorticoid regimens for acceleration of fetal lung maturation in premature labor. American Journal of Obstetrics and Gynecology 1976;124:479- 82.
89. Goodner DM. Antenatal steroids in the treatment of respiratory distress syndrome. 9th World Congress of Gynecology and Obstetrics; 1979 October 26-31; Tokyo, Japan. 1979:362.
90. Grgic G, Fatusic Z, Bogdanovic G. Stimulation of fetal lung maturation with dexamethasone in unexpected premature labor. Medicinski Arhiv 2003;57(5-6):291-4.
91. Barker DJP. Mothers, babies and health in later life. 2nd Edition. London: Churchill Livingstone, 1998.
92. Baud O, Foix-L'Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. New England Journal of Medicine 1999;341:1190-6.
93. Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 1993;341(8841):339-41.
94. Clark PM. Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult disease hypothesis. European Journal of Pediatrics 1998;157(1 Suppl):S7-S10.
95. Collaborative Group on Antenatal Steroid Therapy. Effects of antenatal dexamethasone administration in the infant: long-term followup. Journal of Pediatrics 1984;104:259-67.
96. Crowley P, Chalmers I, Keirse MJNC. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. British Journal of Obstetrics and Gynaecology 1990;97:11-25.
97. Crowther CA, Harding J. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. In: Cochrane Database of Systematic Reviews, 2, 2000.
98. Dodic M, Wintour EM, Whitworth JA, Coghlan JP. Effect of steroid hormones on blood pressure. Clinical & Experimental Pharmacology & Physiology 1999;26(7):550-2.
99. Doyle LW. Victorian Infant Collaborative Study Group. Outcome at 5 years of age of children 23 to 27 weeks' gestation: refining the prognosis. Pediatrics 2001;108(1):134-41.
100. Doyle LW, Casalaz D. Victorian Infant Collaborative Study Group. Outcome at 14 years of extremely low birthweight infants: a regional study. Archives of Diseases in Childhood: Fetal and Neonatal Edition 2001;85(3):F159- F164.
101. Edwards LJ, Coulter CL, Symonds ME, McMillen IC. Prenatal undernutrition, glucocorticoids and the programming of adult hypertension. Clinical & Experimental Pharmacology & Physiology 2001;28(11):938-41.
102. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd.
103. Higgins JPT, Green S, editors. Cochrane Reviewers' Handbook 4.2.5 [updated May 2005]; Section 6. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd.
104. Huang WL, Beazley LD, Quinlivan JA, Evans SF, Nenham JP, Dunlop SA. Effect of corticosteroids on brain growth in fetal sheep. Obstetrics & Gynecology 1999;94(2):213-8.
105. Imseis HM, Iams JD. Glucocorticoid use in patients with preterm premature rupture of fetalmembranes. Seminars in Perinatology 1996;20(5): 439-50.
106. Jobe AH, Wada N, Berry LM, Ikegami M, Ervin MG. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. American Journal of Obstetrics and Gynecology 1998;178(5):880-5.
107. Liggins GC. Premature delivery of foetal lambs infused with corticosteroids. Journal of Endocrinology 1969;45:515-23.
108. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50(4):515-25.
109. Liggins GC. Prenatal glucocorticoid treatment: prevention of respiratory distress syndrome. Lung maturation and the prevention of hyaline membrane disease, Report of the Seventieth Ross Conference on Pediatric Research, Columbus, Ohio. 1976:97-103.
110. National Institutes of Health (NIH) Consensus Development Conference Statement. Effect of corticosteroids for fetal maturation on perinatal outcomes. American Journal of Obstetrics and Gynecology 1994;173:246-52.
111. Padbury JF, Ervin MG, Polk DH. Extrapulmonary effects of antenatally administered steroids. Journal of Pediatrics 1996;128(2):167-72.
112. The Cochrane Collaboration. Review Manager (RevMan). 4.1 for Windows. Oxford, England: The Cochrane Collaboration, 2000.
113. Schwab M, Roedel M, Akhtar Anwar M, Muler T, Schubert H, Buchwalder LF, et al. Effects of betamethasone administration to the fetal sheep in late gestation on fetal cerebral blood flow. Journal of Physiology 2000;528(3):619-32.
114. Seckl JR, Cleasby M, Nyirenda MJ. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming. Kidney International 2000;57(4):1412-7.
115. Turrentine MA, Wilson PD, Wilkins IA. A retrospective analysis of the effect of antenatal steroid on the incidence of respiratory distress syndrome in preterm twin pregnancies. American Journal of Perinatology 1996;13(6):351-4.
116. Vyas J, Kotecha S. Effects of antenatal and postnatal corticosteroids on the pretermlung. Archives of Disease in Childhood: Fetal and Neonatal Edition 1997;77(2):F147-F150.
117. Reynolds LA, Tansey EM. Prenatal corticosteroids for reducing morbidity and mortality after preterm birth. The transcript of a Witness Seminar. London: The Wellcome Trust Centre for History of Medicine at UCL, 2005; Vol. 25.
118. Crowley P. Prophylactic corticosteroids for preterm birth. In: Cochrane Database of Systematic Reviews, 1, 1996.